Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function-Reference-Cited by-同舟云学术

Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function

Published:2008-10-15 Issue:S1 Volume:1 Page:S58-S61
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Heller F,Fromm A,Gitter A H,Mankertz J,Schulzke J-D

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi200846.pdf

Reference15 articles.

1. Schmitz, H. et al. A decrease in tight junction complexity contributes to the severely impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116, 301–309 (1999).

2. Strater, J. et al. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113, 160–167 (1997).

3. Gitter, A.H., Bendfeldt, K., Schulzke, J.D. & Fromm, M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 14, 1749–1753 (2000).

4. Gitter, A.H., Wullstein, F., Fromm, M. & Schulzke, J.D. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121, 1320–1328 (2001).

5. Soderholm, J.D. et al. Increased epithelial uptake of protein antigens in the ileum of Crohn’s disease mediated by tumour necrosis factor alpha. Gut 53, 1817–1824 (2004).

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing Treatment Options for IBD through Drug Repurposing;Current Pharmaceutical Design;2024-09

2. Advancements in ulcerative colitis management: A critical assessment of etrasimod therapy;Health Sciences Review;2024-09

3. Chronic skin damage induces small intestinal damage via IL-13-induced apoptosis;Clinical and Experimental Immunology;2024-06-25

4. Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators;Pharmaceuticals;2024-04-11

5. Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis;Current Pharmaceutical Design;2024-02